Degenerative and regenerative peripheral processes are associated with persistent painful chemotherapy-induced neuropathies in males and females.

George T Naratadam, Jennifer Mecklenburg, Sergey A Shein, Yi Zou, Zhao Lai, Alexei V Tumanov, Theodore J Price, Armen N Akopian
Author Information
  1. George T Naratadam: South Texas Medical Scientist Training Program (STX-MSTP), Integrated Biomedical Sciences (IBMS) Program, The Long School of Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA.
  2. Jennifer Mecklenburg: Department of Endodontics, School of Dentistry, University of Texas Health Science Center at San Antonio (UTHSCSA), 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA.
  3. Sergey A Shein: Department of Microbiology, Immunology and Molecular Genetics, The Long School of Medicine, UTHSCSA, San Antonio, TX, 78229, USA.
  4. Yi Zou: Department of Molecular Medicine, The Long School of Medicine, UTHSCSA, San Antonio, TX, 78229, USA.
  5. Zhao Lai: Department of Molecular Medicine, The Long School of Medicine, UTHSCSA, San Antonio, TX, 78229, USA.
  6. Alexei V Tumanov: South Texas Medical Scientist Training Program (STX-MSTP), Integrated Biomedical Sciences (IBMS) Program, The Long School of Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA. Tumanov@UTHSCSA.edu.
  7. Theodore J Price: School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, TX, 75080, USA. Price@utdallas.edu.
  8. Armen N Akopian: South Texas Medical Scientist Training Program (STX-MSTP), Integrated Biomedical Sciences (IBMS) Program, The Long School of Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA. Akopian@UTHSCSA.edu.

Abstract

This study investigated the time course of gene expression changes during the progression of persistent painful neuropathy caused by paclitaxel (PTX) in male and female mouse hindpaws and dorsal root ganglia (DRG). Bulk RNA-seq was used to examine these gene expression changes at 1, 16, and 31 days post-last PTX. At these time points, differentially expressed genes (DEGs) were predominantly related to the reduction or increase in epithelial, skin, bone, and muscle development and to angiogenesis, myelination, axonogenesis, and neurogenesis. These processes are accompanied by the regulation of DEGs related to the cytoskeleton, extracellular matrix organization, and cellular energy production. This gene plasticity during the progression of persistent painful neuropathy could be interpreted as a biological process linked to tissue regeneration/degeneration. In contrast, gene plasticity related to immune processes was minimal at 1-31 days after PTX. It was also noted that despite similarities in biological processes and pain chronicity between males and females, specific DEGs differed dramatically according to sex. The main conclusions of this study are that gene expression plasticity in hindpaw and DRG during PTX neuropathy progression similar to tissue regeneration and degeneration, minimally affects immune system processes and is heavily sex-dependent at the individual gene level.

Keywords

References

  1. J Pain. 2009 May;10(5):447-85 [PMID: 19411059]
  2. Neurobiol Dis. 2020 Jul;141:104877 [PMID: 32360664]
  3. Nat Commun. 2020 Jan 14;11(1):264 [PMID: 31937758]
  4. Brain Behav Immun. 2007 Jul;21(5):599-616 [PMID: 17187959]
  5. J Pain. 2016 Jul;17(7):775-86 [PMID: 26979998]
  6. Neuron. 2021 Sep 1;109(17):2691-2706.e5 [PMID: 34473953]
  7. J Neurosci. 2020 Sep 16;40(38):7203-7215 [PMID: 32817327]
  8. Front Pharmacol. 2021 Nov 05;12:735075 [PMID: 34803684]
  9. Brain. 2019 May 1;142(5):1215-1226 [PMID: 30887021]
  10. Science. 2022 Apr;376(6588):86-90 [PMID: 35357926]
  11. Nat Protoc. 2014 Jan;9(1):171-81 [PMID: 24385147]
  12. Elife. 2017 Nov 10;6: [PMID: 29125463]
  13. J Peripher Nerv Syst. 2008 Mar;13(1):27-46 [PMID: 18346229]
  14. Behav Brain Sci. 1997 Sep;20(3):371-80; discussion 435-513 [PMID: 10097000]
  15. Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):1 [PMID: 34061953]
  16. Philos Trans R Soc Lond B Biol Sci. 2019 Nov 11;374(1785):20190289 [PMID: 31544610]
  17. J Neurosci. 2017 Aug 2;37(31):7481-7499 [PMID: 28674170]
  18. Nat Neurosci. 2015 Aug;18(8):1081-3 [PMID: 26120961]
  19. Front Immunol. 2017 Aug 21;8:1014 [PMID: 28871264]
  20. PLoS One. 2016 Mar 03;11(3):e0150606 [PMID: 26938654]
  21. Am J Sports Med. 2022 Jul;50(8):2247-2257 [PMID: 35604307]
  22. Front Pain Res (Lausanne). 2023 Oct 31;4:1274811 [PMID: 38028432]
  23. Sci Transl Med. 2022 May 11;14(644):eabj9954 [PMID: 35544595]
  24. JCI Insight. 2022 Mar 8;7(5): [PMID: 35260535]
  25. Nat Rev Neurosci. 2018 Jul;19(7):383-384 [PMID: 29765159]
  26. Front Neuroendocrinol. 2013 Oct;34(4):350-66 [PMID: 23872333]
  27. Pain. 1996 May-Jun;65(2-3):123-67 [PMID: 8826503]
  28. Eur J Pharmacol. 2022 Oct 15;933:175288 [PMID: 36122757]
  29. Nat Methods. 2013 Nov;10(11):1096-8 [PMID: 24056875]
  30. Am J Physiol Endocrinol Metab. 2013 Nov 1;305(9):E1154-64 [PMID: 24022869]
  31. Pain Rep. 2020 Mar 27;5(2):e818 [PMID: 32440611]
  32. Brain. 2023 Feb 13;146(2):749-766 [PMID: 35867896]
  33. J Cell Biochem. 2020 Feb;121(2):1635-1648 [PMID: 31535407]
  34. J Pain Res. 2019 Nov 08;12:3013-3023 [PMID: 31807058]
  35. Circulation. 2022 Mar;145(9):659-674 [PMID: 35100526]
  36. J Comp Neurol. 2023 May;531(7):814-835 [PMID: 36808110]
  37. J Neurosci. 2020 Sep 9;40(37):7080-7090 [PMID: 32801151]
  38. Anesth Analg. 2006 May;102(5):1485-90 [PMID: 16632831]
  39. Neuroscience. 2013 Dec 3;253:132-41 [PMID: 23994182]
  40. J Biol Chem. 2015 May 15;290(20):12603-13 [PMID: 25787078]
  41. J Neurosci. 2010 Nov 10;30(45):15113-23 [PMID: 21068317]
  42. Pain. 1988 Jan;32(1):77-88 [PMID: 3340425]
  43. iScience. 2019 Oct 25;20:449-465 [PMID: 31627131]
  44. Neuron. 2020 Oct 14;108(1):128-144.e9 [PMID: 32810432]
  45. J Neurosci Methods. 2014 Oct 30;236:86-91 [PMID: 25128723]
  46. Int J Mol Sci. 2021 Feb 16;22(4): [PMID: 33669272]
  47. Pain. 2020 Oct;161(10):2344-2352 [PMID: 32427749]
  48. J Neuroinflammation. 2021 Feb 18;18(1):48 [PMID: 33602238]
  49. J Neurosci. 2011 Oct 26;31(43):15450-4 [PMID: 22031891]
  50. Rheumatology (Oxford). 2018 Mar 1;57(3):429-440 [PMID: 28968842]
  51. Mol Pain. 2011 Sep 28;7:74 [PMID: 21951975]
  52. J Immunol. 2001 Apr 1;166(7):4697-704 [PMID: 11254730]
  53. Int J Mol Sci. 2023 Mar 15;24(6): [PMID: 36982659]
  54. Sci Rep. 2023 Dec 12;13(1):22057 [PMID: 38086903]
  55. Neural Plast. 2021 Aug 2;2021:5597139 [PMID: 34394340]
  56. Glia. 2007 Jan 15;55(2):189-201 [PMID: 17078023]
  57. bioRxiv. 2023 Aug 03;: [PMID: 37781572]
  58. Mol Pain. 2014 Jul 04;10:45 [PMID: 24993495]
  59. Science. 2016 Nov 4;354(6312):572-577 [PMID: 27811267]
  60. Cancer Treat Rev. 2014 Aug;40(7):872-82 [PMID: 24830939]
  61. Neuro Oncol. 2012 Sep;14 Suppl 4:iv45-54 [PMID: 23095830]
  62. Brain Behav Immun. 2022 Mar;101:246-263 [PMID: 35065194]
  63. J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1704-1723 [PMID: 34427057]
  64. Sci Rep. 2022 Oct 11;12(1):17012 [PMID: 36220867]
  65. Sci Rep. 2020 Sep 17;10(1):15278 [PMID: 32943709]

Grants

  1. R01 NS112263/NINDS NIH HHS
  2. T32 GM113896/NIGMS NIH HHS
  3. GM113896/NIGMS NIH HHS
  4. R01 NS065926/NINDS NIH HHS
  5. R01 DE029187/NIDCR NIH HHS
  6. NS102161/NINDS NIH HHS
  7. NS112263/NINDS NIH HHS
  8. P30 CA054174/NCI NIH HHS
  9. S10 OD030432/NIH HHS
  10. R01 NS102161/NINDS NIH HHS
  11. S10 OD021805/NIH HHS
  12. UC2 AR082195/NIAMS NIH HHS

MeSH Term

Animals
Female
Male
Mice
Ganglia, Spinal
Paclitaxel
Peripheral Nervous System Diseases
Nerve Regeneration
Neuralgia
Transcriptome
Pain

Chemicals

Paclitaxel

Word Cloud

Created with Highcharts 10.0.0geneprocessesneuropathyPTXexpressionprogressionpersistentpainfulDRGDEGsrelatedplasticitystudytimechangesBulkbiologicaltissueimmunepainmalesfemalessysteminvestigatedcoursecausedpaclitaxelmalefemalemousehindpawsdorsalrootgangliaRNA-sequsedexamine11631 dayspost-lastpointsdifferentiallyexpressedgenespredominantlyreductionincreaseepithelialskinbonemuscledevelopmentangiogenesismyelinationaxonogenesisneurogenesisaccompaniedregulationcytoskeletonextracellularmatrixorganizationcellularenergyproductioninterpretedprocesslinkedregeneration/degenerationcontrastminimal1-31 daysalsonoteddespitesimilaritieschronicityspecificdiffereddramaticallyaccordingsexmainconclusionshindpawsimilarregenerationdegenerationminimallyaffectsheavilysex-dependentindividuallevelDegenerativeregenerativeperipheralassociatedchemotherapy-inducedneuropathiesRNAsequencingDegenerationImmunePaclitaxelPainfulPersistentchronicRegenerationSexdifference

Similar Articles

Cited By